RXST vs PACB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

RXST

56.4
AI Score
VS
RXST Wins

PACB

44.3
AI Score

Investment Advisor Scores

RXST

56score
Recommendation
BUY

PACB

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric RXST PACB Winner
Forward P/E 116.2791 0 Tie
PEG Ratio 0 -0.17 Tie
Revenue Growth 0.3% -1.9% RXST
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 56.4/100 44.3/100 RXST
Profit Margin -36.8% -82.5% RXST
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD RXST

Relative Price Performance (Last 90 Days)

RXST 1M: -0.6% · 3M: -8.8% PACB 1M: +45.6% · 3M: +52.9%

Current Technical Phase

RXST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.7 · Price: $4.90

PACB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (23.4% over 20 days), RSI 56

RSI (14): 55.9 · Price: $2.14

Fundamentals Snapshot

Metric RXST PACB
Market Cap — —
Forward P/E -7.2 -5.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.8% 0.3%
Operating Margin -0.4% -1.1%
EPS -1.14 -0.43
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RXST is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.